Clinical Trials Logo

Healthy Subject clinical trials

View clinical trials related to Healthy Subject.

Filter by:

NCT ID: NCT04941313 Completed - Healthy Subject Clinical Trials

Phase 1 Study of 3D229 in Healthy Subjects

Start date: July 27, 2021
Phase: Phase 1
Study type: Interventional

This is a Phase 1 Study to Evaluate the Safety and tolerability of 3D-229 in health subjects

NCT ID: NCT04803682 Completed - Healthy Subject Clinical Trials

A Smoking Prevention Program (ASPIRE) and Mentoring for Preventing Smoking Among High School Youths

Start date: January 8, 2016
Phase: Early Phase 1
Study type: Interventional

This early phase I trial studies how well A Smoking Prevention Interactive Experience (ASPIRE) program and mentorship works in preventing smoking in high school students. ASPIRE is an online-based, youth-centered tobacco prevention and cessation program. The goal of this research study is to learn if training eleventh grade high school students to be tobacco-free role models and mentors for ninth grade high school students is possible and will positively influence the younger peers.

NCT ID: NCT04312568 Completed - Healthy Subject Clinical Trials

Evaluate Safety, Tolerability and Pharmacokinetics of Fadanafil (XZP-5849)in Chinese Healthy Adult Male Subjects

Start date: August 10, 2018
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety , tolerability, and pharmacokinetics of ascending single dose Fadanafil (XZP-5849)in Chinese healthy adult male subjects. This is the first XZP-5849 clinical study

NCT ID: NCT04290585 Completed - Healthy Subject Clinical Trials

Technology and Health Communication in Improving Health Outcomes in Patients Scheduled for Mammography

Start date: March 5, 2014
Phase: N/A
Study type: Interventional

This pilot clinical trial studies how well technology and health communication works in improving health outcomes in patients scheduled for mammography screening. The Mobile Mammography Screening Program provides a vital health service and it is important that all women scheduled for an appointment show-up to be screened. Technology and health communication may help decrease no-show rates among patients scheduled for mammography screening.

NCT ID: NCT04211766 Completed - Healthy Subject Clinical Trials

Fiber and Fish Oil Supplements for the Prevention of Colorectal Cancer

Start date: January 5, 2021
Phase: N/A
Study type: Interventional

This trial studies how fiber and fish oil supplements affect the metabolism and activities of colon cells in healthy individuals. Diet is an important risk factor for colorectal cancer, and several dietary components important in colorectal cancer prevention are modified by gut microbial metabolism. Giving fiber and fish oil supplements may inhibit the growth of gut cells and ultimately reduce risk of colorectal cancer.

NCT ID: NCT04062955 Completed - Healthy Subject Clinical Trials

Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants

Start date: October 28, 2019
Phase: N/A
Study type: Interventional

This trial studies the effects of a dietary intervention based on the Alternative Healthy Eating Index (AHEI) on inflammatory markers and breast density in healthy participants. The AHEI is a quantifiable measure of diet quality designed to target food and macronutrient sources that are associated with chronic disease risk. Adherence to the AHEI may be associated with a reduction in inflammatory biomarkers and sex steroid hormone levels compared to other dietary patterns/scores.

NCT ID: NCT04023903 Completed - Healthy Subject Clinical Trials

A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults

Start date: April 4, 2019
Phase: Phase 1
Study type: Interventional

Food effect part: To investigate the effect of food on the pharmacokinetics of RTA 402 and evaluate the safety of RTA 402 in Japanese healthy male adults, using the capsule formulations. Caucasian subject part: To investigate the pharmacokinetics of a single dose of RTA 402 administered in the fasted state and compare the pharmacokinetics with those observed in Japanese healthy male adults in the food effect part

NCT ID: NCT03963323 Completed - Healthy Subject Clinical Trials

Glucosamine and Chondroitin in Gut in Preventing People From Inflammation

Start date: May 11, 2018
Phase: Phase 1
Study type: Interventional

This trial studies glucosamine and chondroitin in preventing inflammation. Glucosamine and chondroitin often used as a dietary supplement to promote joint health may have a preventive role in inflammation and cancer. This trial may help identify the bacteria that help process them in the gut.

NCT ID: NCT03827161 Completed - Overweight Clinical Trials

Glucosamine and Chondroitin in Preventing Inflammation in Overweight Patients

Start date: August 1, 2017
Phase: Phase 1
Study type: Interventional

This trial studies glucosamine and chondroitin in preventing inflammation in overweight patients. Chronic inflammation contributes to cancer formation, and biomarkers of inflammation have been associated with cancer risk. Glucosamine and chondroitin may prevent inflammation and this trial may help identify the bacteria that help process them in the gut.

NCT ID: NCT03814200 Completed - Healthy Subject Clinical Trials

A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects

Start date: January 3, 2019
Phase: Phase 1
Study type: Interventional

The study will investigate the effect of rifampicin on the uptake and breakdown of ACT-246475 in healthy subjects